top of page


HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China

January 23, 2023 at 1:11:25 PM

Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

December 27, 2022 at 1:44:59 PM

Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer

December 22, 2022 at 1:22:57 PM

Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited

December 12, 2022 at 5:08:14 AM

China Pharma Holdings Acquires Dry Eye Disease Therapeutic Device Project

December 8, 2022 at 2:09:12 PM

Baozun Acquires Gap Greater China and Establishes Brand Management as a New Business Line

November 10, 2022 at 8:27:49 AM

bottom of page